Dr. John Buse shares what is new in the treatment of diabetes, and highlights the benefits that SGLT2 inhibitors and GLP-1 receptor agonists can offer to patients, among other topics related to diabetes treatment.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
